Abbot
Abbott’s (NYSE:ABT) adjusted earnings per share (EPS) grew at a CAGR of 11% from $2.16 in 2015 to $3.26 in 2019. This was virtually 2x the CAGR of 5.1% for Medtronic’s (NYSE:MDT) adjusted EPS, which grew from $4.28 in fiscal 2015 to $5.22 in fiscal 2019. This clubbed with Abbott’s decrease debt ranges explains its increased value to earnings a number of of 25x compared to Medtronic’s 20x based mostly on the present market value and common consensus earnings estimate for 2020. On this dashboard, Medtronic vs Abbott: How Have Revenues & Different Key Metrics Modified Over Latest Years?, we have now analyzed the revenues and different key metrics of each the businesses over latest years.
#1 Market Cap: Each Medtronic And Abbott’s Market Cap Is Related
- Medtronic’s market capitalization grew from $109 billion in 2015 to $152 billion in 2019.
- Abbott’s market capitalization grew from $68 billion to $154 billion over the identical interval.
#2 Revenues: Medtronic’s Revenues of $31 Billion Are Barely Decrease Than $32 Billion For Abbott.
…